Janux Therapeutics, Inc. (JANX)

Janux Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	846	833	3,162	496	548	814
Market Cap Growth	-54.54%	-73.65%	537.19%	-9.45%	-32.65%	-
Enterprise Value	-81.23	-113.52	2,158	175.29	245.61	438.76
Last Close Price	13.92	13.80	53.54	10.73	13.17	19.73
PE Ratio	-	-7.54	-41.83	-8.13	-8.66	-14.19
PS Ratio	86.32	83.33	298.67	61.40	63.64	223.74
PB Ratio	0.89	0.87	3.09	1.44	1.71	2.22
P/TBV Ratio	0.90	0.89	2.81	1.37	1.70	1.27
P/FCF Ratio	-	-10.01	-71.59	-9.47	-11.10	-44.09
P/OCF Ratio	-	-10.13	-72.18	-9.81	-12.77	-47.93
EV/Sales Ratio	-	-11.35	203.86	21.69	28.52	120.64
EV/EBITDA Ratio	-	0.73	-22.30	-2.47	-3.71	-13.37
EV/EBIT Ratio	-	0.72	-21.84	-2.40	-3.66	-13.32
EV/FCF Ratio	-	1.36	-48.86	-3.34	-4.98	-23.77
Debt / Equity Ratio	0.02	0.02	0.02	0.07	0.08	0
Debt / EBITDA Ratio	-0.14	-0.14	-0.24	-0.35	-0.38	-0.01
Debt / FCF Ratio	-0.27	-0.27	-0.52	-0.47	-0.51	-0.01
Net Debt / Equity Ratio	-0.99	-0.99	-0.98	-0.93	-0.94	-1.02
Net Debt / EBITDA Ratio	6.07	6.07	10.35	4.50	4.55	11.42
Net Debt / FCF Ratio	11.34	11.34	22.69	6.09	6.11	20.30
Asset Turnover	0.01	0.01	0.01	0.02	0.02	0.02
Quick Ratio	38.67	38.67	58.72	26.40	19.81	29.30
Current Ratio	39.04	39.04	59.21	26.80	20.14	29.46
Return on Equity (ROE)	-11.48%	-11.48%	-10.09%	-17.53%	-18.36%	-17.50%
Return on Assets (ROA)	-15.28%	-15.28%	-13.71%	-19.61%	-18.04%	-16.63%
Return on Invested Capital (ROIC)	-954.78%	-954.78%	-418.83%	-274.23%	-530.83%	-1126.36%
Return on Capital Employed (ROCE)	-15.61%	-15.61%	-14.01%	-20.42%	-18.78%	-17.33%
Earnings Yield	-13.16%	-13.26%	-2.39%	-12.30%	-11.54%	-7.05%
FCF Yield	-9.65%	-9.99%	-1.40%	-10.56%	-9.01%	-2.27%
Buyback Yield / Dilution	-0.59%	-0.59%	-22.55%	-12.00%	-0.09%	-25.31%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q